1 – 57 of 57
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The HLA region in ANCA-associated vasculitis : characterisation of genetic associations in a Scandinavian patient population
(
- Contribution to journal › Article
-
Mark
Low CD4 + T cell count is related to specific anti-nuclear antibodies, IFNα protein positivity and disease activity in systemic lupus erythematosus pregnancy
(
- Contribution to journal › Article
-
Mark
A survey of ficolin-3 activity in Systemic Lupus Erythematosus reveals a link to hematological disease manifestations and autoantibody profile
(
- Contribution to journal › Article
- 2023
-
Mark
Low-density granulocytes are related to shorter pregnancy duration but not to interferon alpha protein blood levels in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction : a multicentre study
(
- Contribution to journal › Article
-
Mark
Stratified Genetic Analysis Reveals Sex Differences In MPO-ANCA-associated Vasculitis
(
- Contribution to journal › Article
- 2022
-
Mark
Four Systemic Lupus Erythematosus Subgroups, Defined by Autoantibodies Status, Differ Regarding HLA-DRB1 Genotype Associations and Immunological and Clinical Manifestations
(
- Contribution to journal › Article
-
Mark
Mer-tyrosine kinase : a novel susceptibility gene for SLE related end-stage renal disease
(
- Contribution to journal › Article
-
Mark
Complement C4 copy number variation is linked to SSA/Ro and SSB/La autoantibodies in systemic inflammatory autoimmune diseases
(
- Contribution to journal › Article
-
Mark
Identification and Functional Characterization of a Novel Susceptibility Locus for Small Vessel Vasculitis with MPO-ANCA
(
- Contribution to journal › Article
- 2021
-
Mark
Quick Systemic Lupus Activity Questionnaire (Q-SLAQ) : A simplified version of SLAQ for patient-reported disease activity
(
- Contribution to journal › Article
-
Mark
De novo lupus nephritis during treatment with belimumab
(
- Contribution to journal › Article
-
Mark
Contributions of de novo variants to systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Toll-like receptors revisited; A possible role for TLR1 in lupus nephritis
(
- Contribution to journal › Letter
-
Mark
Interaction between the STAT4 rs11889341(T) risk allele and smoking confers increased risk of myocardial infarction and nephritis in patients with systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Activated low-density granulocytes in peripheral and intervillous blood and neutrophil inflammation in placentas from SLE pregnancies
(
- Contribution to journal › Article
-
Mark
Variants in BANK1 are associated with lupus nephritis of European ancestry
(
- Contribution to journal › Article
-
Mark
Molecular pathways in patients with systemic lupus erythematosus revealed by gene-centred DNA sequencing
(
- Contribution to journal › Article
- 2020
-
Mark
Plasma C4d Correlates With C4d Deposition in Kidneys and With Treatment Response in Lupus Nephritis Patients
(
- Contribution to journal › Article
-
Mark
Autoantibody and cytokine profiles during treatment with belimumab in patients with systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
NCF1-339 polymorphism is associated with altered formation of neutrophil extracellular traps, high serum interferon activity and antiphospholipid syndrome in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Lymphopenia as a risk factor for neurologic involvement and organ damage accrual in patients with systemic lupus erythematosus : A multi-center observational study
(
- Contribution to journal › Article
- 2019
-
Mark
Evaluation of a Novel Immunoassay for Quantification of C1q for Clinical Diagnostic Use
(
- Contribution to journal › Article
-
Mark
Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Whole-genome sequencing identifies complex contributions to genetic risk by variants in genes causing monogenic systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Sex differences in clinical presentation of systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectives
(
- Contribution to journal › Scientific review
-
Mark
A rare regulatory variant in the MEF2D gene affects gene regulation and splicing and is associated with a SLE sub-phenotype in Swedish cohorts
(
- Contribution to journal › Article
-
Mark
Genetic variations in A20 DUB domain provide a genetic link to citrullination and neutrophil extracellular traps in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status
(
- Contribution to journal › Article
- 2018
-
Mark
Smoking reduces the efficacy of belimumab in mucocutaneous lupus
(
- Contribution to journal › Article
-
Mark
Cardiovascular disease in systemic lupus erythematosus is associated with increased levels of biomarkers reflecting receptor-activated apoptosis
(
- Contribution to journal › Article
-
Mark
DNA methylation mapping identifies gene regulatory effects in patients with systemic lupus erythematosus
(
- Contribution to journal › Article
- 2017
-
Mark
Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
A single nucleotide polymorphism in the NCF1 gene leading to reduced oxidative burst is associated with systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Novel risk genes for systemic lupus erythematosus predicted by random forest classification
(
- Contribution to journal › Article
-
Mark
Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody-associated vasculitis
(
- Contribution to journal › Letter
- 2016
-
Mark
Platelet-derived S100A8/A9 and cardiovascular disease in systemic lupus erythematosus.
2016) In Arthritis & Rheumatology(
- Contribution to journal › Article
-
Mark
Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts.
(
- Contribution to journal › Article
- 2015
-
Mark
Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus.
(
- Contribution to journal › Article
- 2013
-
Mark
Association of STAT4 Polymorphism with Severe Renal Insufficiency in Lupus Nephritis.
(
- Contribution to journal › Article
-
Mark
HLA-DRB1*04/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Coronary Heart Disease in Systemic Lupus Erythematosus Is Associated With Interferon Regulatory Factor-8 Gene Variants
(
- Contribution to journal › Article
-
Mark
Genes identified in Asian SLE GWASs are also associated with SLE in Caucasian populations
(
- Contribution to journal › Article
- 2012
-
Mark
Clinical manifestations and anti-phospholipid antibodies in 712 patients with systemic lupus erythematosus: evaluation of two diagnostic assays.
2012) In Rheumatology (Oxford, England)(
- Contribution to journal › Article
-
Mark
Genetically Distinct Subsets within ANCA-Associated Vasculitis
(
- Contribution to journal › Article
- 2011
-
Mark
Mutations in genes encoding complement inhibitors CD46 and CFH affect the age at nephritis onset in patients with systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
A candidate gene study of the type I interferon pathway implicates IKBKE and IL8 as risk loci for SLE
(
- Contribution to journal › Article
- 2010
-
Mark
A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus
(
- Contribution to journal › Article
- 2009
-
Mark
A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus
(
- Contribution to journal › Article
- 2008
-
Mark
Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5
(
- Contribution to journal › Article
-
Mark
Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX
(
- Contribution to journal › Article
- 2007
-
Mark
Association of a CD24 gene polymorphism with susceptibility to systemic lupus erythematosus
(
- Contribution to journal › Article